AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

The path to bringing a new drug to market is increasingly complex and costly, with development costs now exceeding $2 billion and timelines approaching a decade. 1,2 The stakes have never been ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...